News
OpenApp take home the Excellence in CSR by an SME Award in Corporate Social Responsibility Award 2018
OpenApp has been awarded the Excellence in CSR by an SME in the Chambers Ireland Corporate Social Responsibility (CSR) Awards 2018. OpenApp won for their project Rare100. Rare diseases affect an estimated 300 million people around the world and 30 million in Europe alone. Despite…
OpenApp Develops Ground Breaking Platform Which Delivers Better Care to Rare Disease Patients
European clinicians treating over 30 million people who suffer from rare and complex diseases are reaping the benefits of European cooperation. A new system developed by Irish health informatics company OpenApp for the European Commission now allows secure online consultations with leading specialists across Europe.…
Launch of Patient Registry for Pulmonary Lung Fibrosis
OpenApp was delighted and proud to attend the launch of the Irish Lung Fibrosis Registry (ILD Registry). OpenApp have worked with The Irish Thoracic Society to deliver a customized patient registry built upon our registry platform. The launch was held in the fitting setting of…
Want to know more about the ERNs?
On 1 March the newly established European Reference Networks (ERNs) began their work. ERNs are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases. (more…)
Job Vacancies
Due to our continued expansion, we are hiring an experienced Product Owner, Application Programmer and a Senior Application Developer. At OpenApp, we offer a promising career with opportunities to progress within the company. All roles are an essential part of our future growth. OpenApp is an…
OpenApp Shortlisted for Prestigious CSR Award
OpenApp are delighted to announce that they have been shortlisted for a ‘Excellence in CSR by an SME’ Award in the Chambers Ireland Corporate Social Responsibility Awards. OpenApp has been short-listed because of our free registry Rare100. The CSR by an SME is dedicated to…